* 1 1 1~1 I I I . I . V e n e z i a -M e s t r e H o s p i t a l , P a e d i a t r i c D i v i s i o n , and KUEhlLIN DICETKI': CC~lcx.
U n i v e r s i t y o f Padova, P a e d i a t r i c D e p a r t m e n t Wilao~i'a ~Iibe.i~c (IVNV) ir ,111 ,IU~IISIIIII.I~ rcLchhlvc cI~\ordcr (11 ~oplicr ~i~clabolibiii. TIIC IIICI;I~O~IC dclccl IS alill UIILIIII~II, ~U I IIIC I O C U S 01 i l~c dtw:~\c 11x5 l~ccii ii~;~ppccl 10 ~I i r o~i i o~~~~~~c l3qI4-q?l, U \ I I I~ p r~l j~n o r p l i t~ [IN, \ iii; ~rlcrs 111 ;~ll'cclcd I;iinilicr, uc .ire iiou, ;ihlc 10 rccogiilrc \VND Irclorc ilic oliact or cliiiical 111a111Icslailo1ls.
, .. , ,.
.. .
-1 2 1 aubjccls Iia\c hccli sludlcd. 'llxy hclongcd to 3 I larnilics having ;il Icnrl oiic all'cctcd nlcnihcr. Gciioli~ic DNA %a\ ,tii,~Iyrcd hy Soutlicr~~ hlols Four dillcrciil prr~hcs wcrc u\cd lor lhc iiii:iIy\i\ or KFLI', Dl3 S 31 ( p u l )~~i (~r p l i i \~i i w11Ii T.IIII). Dl3 S 50 ( p o I y~l t o r~l l~\~~~ UIIII 11.1i111). !)I1 S 26 (polyniurphlsn~ n,illi Ilplil) iiiid KII (~CI~I~O~~~\IUIII:I gei~c. ~~~~I~~i~o r p l i t~i i i w i i l~ RSal). E r t a n M a y a t e p e k , Georg F . Hoffmann, D i r g i t C a r l s s o n * , Agne L a r s s o n ' , and K a t j a B e c k e r . University Children's I l o s p i t a l , l l e i d e l b e t c j ,
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G l u t a t h l o n e s y n t h e t a s e deficiency (GSD) investigations r e v e a l e d t h a t I n GSD LTCl s y~l t i i e s l s 1s s~g n i f l c a n t l y d e c r e a s e d I n c a l c~u r n l o n o p h o r e a c t i v a t e d lnonocytes as w e l l as i n n e u t r o p h i l s ( 1 1 -1 4 % and 7-101, r e s p e c t i v e l y , o f t h e l e v e l s d e t e c t e d i n t l i c p a r e n t s OKc o n t r o l s ) . Endogenous u r l n a r y LTEj r e l a t l v e t o c r e a t l n i r l e S i n c e c y s t e i n y l LTs may b e i m p o r t a n t f o r c e l l u l a r f u n c t i o n s i n t h e c e n t r a l n e r v o u s system, t h e i r i m p a i r e d s y n t h e s i s m i g h t be i n v o l v e d i n t h e p a t h o p h y s i o l o q y o f GSD. Palhology. Hosp~tal Llchlenberg and Charlte Berl~n. Depl of Biochem~slry Unlvers~ty of Notlingham 11-beta-keloth~olase defic~ency IS a rare metabol~c d~sorder wh~ch requlres further lnvestigatlon We report two brothers. 6 9112 years (pat 1) and 4 years (pal 2). who suffered from a 11-B-Ketolh~olase defic~ency (EG 2 3 I 9) wh~ch was conf~rmed by an elevated 2-melhyl-3-hydroxybulyr~c acld and tr~glyglyc~ne excrelion In the urlne Measuremenls of ketolyl~c enzyme acllvlties In f~broblast exlracls from molher and pal 2 showed a low activ~ty of the short c h a~n spec~flc m~lochondr~al th~olase (C51C4) rates = 0 54 and 0 44 rsp ) Both pat~ents had delayed developmenl, neurological features (appalllc syndrome pal 1 and lelraparesis, pal 2 respecllvely) selzures and amaurosls with opt~cus alrophy and d~e d In a metabol~c ac~dollc crlsis alter development of an obstruct~ve cardlomyopathy Destrucllon In the b r a~n Included Ihe par~elal and occ~p~ral cortex vlsual cortex putamen, caput nucle~ caudal1 and claustrum I! 1s assumed that in t h~s fam~ly there is a severe spec~lic form of 1 l-betaKelolhlolase deflc~ency which alfected also tho hoar1 mctabol~sm of tho chlldren
P o s t -T r a u m a t i c S t r c s s C F s c r d c r (PTSD) f o l l o w s a p s y c h o l o g i c a l l y d i s t r e s s i n g c v c n t o u t s i d e t h c c s u a l lluman e x p e r i e n c e . C h a r a c t e r i s t i c symptoms:
r e -e x p e r i e n c i n g t h e t r a u m a t i c e v c n t , a v o i d a n c e o f s t i m u l i a s s o c i a t e d w l t h t h e e v e n t o r numbing o f g e n e r a l r e s p o n s i v e n e s s and i n c r c a s e d a r o u s a l . U s i n g s c m i -s t r u c t u r e d q u e s t i o n n a i r e s , we s t u d i e d b a c k g r o u n d , war t r a u m a s and physicalJpsycho-emotional r e a c t i o n s i n 163 D o s n i a n and 30 C r o a t i a n r c f u g c c s ( m a i n l y m o t h e r s & children) i n a n I t a l i a n Rcd C r o s s camp. R e s u l t s . A d u l t s : PTSD i n most, w i t h p s y c h i a t r i c r e l e v a n c e i n 16. 
d o l c s c e n t s : PTSD w i t h d c f c : i c e mechanisms a g a i n s t a n x i c t y ( r a t i o n a l i s a t i o n and i d c a l i s a t i o n ) . C o n c l u s i o n s : i n f a n t s b c t t c r d c f c n d e d f r o m t r a u m a s p r o i i d i n g m o t h c r s a c t i s a p r o t c c t i v c s h i e l d . R e l c a s i n q t e n s i o n t h r o u g h p l a y 1 s o f t e n
i n e f f e c t i v e i n p r o t c c t l n g C h i l d r e n . A d o l c s c e n t s ' i d c a l i s a t i o n p r o c e s s t c n d s t o c x a s p c r a t c t h e c o n t r a p p o s i t i o n between f r i e n d s and enemies, u n d e r m i n i n g t h c i r sensc o f r e a l i t y and t h c i r p e r s o n
Recent r e s e a r c h i n d i c a t e s t h a t h y p o x i a p r e c e d e s d e a t h in a p p r o x i m a t e l y 80% o f t h e SIDS cases and t h a t SIDS i n f a n t s have a s t i m u l a t e d immune system a t t i m e o f d e a t h . I t has been shown i n i n f a n t s as w e l l as i n s e v e r a l e x p e r i m e n t a l drliinill m o d e l s , t h a t C N S -m a t u r i t y a f f c c t s t h e effectiveness o f a u t o r e s u s c i t a t i o n . I t tias been p o s t u l a t e d t h c l t 11-11
? may b c t h c i n t e r m e d i a r y c a u s i t i g p r o l o n g e d s l e e p itp:lca drid SIDS d u r i n g r e s p i r a t o r y i n f e c t i o n s . To t e s t t h i s , 5 -1 0 days o l d p i g l e t s were g i v e n 11-lI? i n t r a v e n o u s l y ( n = 8 ) o r l n t r a t e c h a l l y ( n = 9 ) p r i o r t o l a r y n g e a l stimulation w i t h R e s p a n i n C t r . 
